Adaptive Platform Trial for Kidney Disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This is a flexible research study for adults with advanced kidney disease. Depending on which part of the study you qualify for, you may test new treatments designed to slow kidney disease, reduce complications, or improve your health while on dialysis or after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have severely reduced kidney function (eGFR below 30) for at least 3 months, OR you are on dialysis, OR you have a working kidney transplant
- You can understand and sign consent to participate in research
- You qualify for at least one of the active study treatment arms (the research team will determine this)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with a primary (main) kidney disease who can regularly see a kidney doctor. It sets up and includes patients for possible interventional (active) research studies, which may help improve kidney care for future patients.
This study evaluates whether MyRenalCare, a digital platform that helps patients with chronic kidney disease (CKD) monitor and manage their condition, improves health outcomes and patient experience. Researchers will compare people using the platform with those receiving standard care, and interview patients and staff about their experiences.
This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This trial tests an experimental drug called AION-301 for people with chronic kidney disease (CKD). The goal is to see if it's safe and may help slow kidney decline. It's given by IV infusion and compared to a placebo (inactive infusion).
This study tests a phone app (with check-ins on things like blood pressure and weight) to help prevent complications in people with advanced chronic kidney disease. You may be a good match if you’re high risk and can actively measure and share your health data with a kidney care team.
Hear when a new Chronic Kidney Disease (Stages 4 and 5) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.